RAPT Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares


You May Also Like

Beta Bionics Announces Final Closing of Its $63 Million Series B Financing

New investors include ArrowMark, LifeSci Venture Partners, and strategic partner, DexcomRTW made an additional ...

The Board of Directors of Orion Corporation decided on an incentive plan for key persons

ORION CORPORATION         STOCK EXCHANGE RELEASE      6 FEBRUARY  2019  AT 12.45 PM EET               The ...